
Ready-to-use Tesamorelin in a multidose pre-filled pen.
30mg Tesamorelin multidose pre-filled pen — no reconstitution required. Swiss-manufactured pharma-grade GHRH analogue.
A pre-filled, multidose pen delivering pharmaceutical-grade Tesamorelin — a synthetic growth-hormone-releasing factor (GRF) analogue clinically validated for visceral fat reduction.
Stimulates the pituitary to release endogenous GH in a physiological pulsatile pattern.
Typical research dosing: 1–2mg daily subcutaneous, cycled.
Dial dose on pre-filled pen; subcutaneous injection. Excipients: disodium phosphate dihydrate, sterile water, phenol, propylene glycol.
Refrigerate at 2–8 °C. Protect from light.
Most users report measurable changes within 2–4 weeks of consistent use. Full results typically emerge across an 8–12 week protocol.
Yes. Our compounds are designed to be modular. Pair with complementary stacks from Recovery, Longevity, or Metabolic collections — our specialists can recommend a structure.
Every batch ships with a Certificate of Analysis verifying purity above 99% from an independent ISO-accredited lab.
Unopened, temperature-intact vials may be returned within 14 days. Opened compounds are non-returnable for safety reasons.
MetabolicSLU-PP-332 AMPK activator that mimics the metabolic signature of endurance training.
Body CompositionTesamorelin Pro 30mg/3mL — clinically backed GHRH analog for visceral adiposity.
MetabolicRetatrutide 50mg/3mL — triple agonist of GLP-1, GIP, and Glucagon receptors.
LongevityNAD+ Max 1000mg/3mL — ultra-high-purity NAD+ for mitochondrial and longevity protocols.